These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8287551)

  • 1. Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure.
    Jakob G; Mair J; Vorderwinkler KP; Judmaier G; König P; Zwierzina H; Pichler M; Puschendorf B
    Clin Chem; 1994 Jan; 40(1):96-100. PubMed ID: 8287551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.
    Jakob G; Mair J; Pichler M; Puschendorf B
    Br Heart J; 1995 Feb; 73(2):145-50. PubMed ID: 7696024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
    Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
    J Gastroenterol Hepatol; 1997 Mar; 12(3):233-6. PubMed ID: 9142641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
    Tsutamoto T; Kanamori T; Wada A; Kinoshita M
    J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases.
    Vorderwinkler KP; Artner-Dworzak E; Jakob G; Mair J; Diensti F; Pichler M; Puschendorf B
    Clin Chem; 1991 Feb; 37(2):186-90. PubMed ID: 1847093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of atrial natriuretic factor in the plasma and urine of patients with and without heart failure.
    Agnoletti G; Panzali AF; Ferrari R
    Int J Cardiol; 1993 Jul; 40(2):179-82. PubMed ID: 8394286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
    Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
    Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Matsuo H
    J Lab Clin Med; 1987 Jun; 109(6):706-10. PubMed ID: 3035037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium.
    Chaykovska L; Heunisch F; von Einem G; Hocher CF; Tsuprykov O; Pavkovic M; Sandner P; Kretschmer A; Chu C; Elitok S; Stasch JP; Hocher B
    PLoS One; 2018; 13(4):e0195828. PubMed ID: 29649334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.
    Wood PJ; Ross G; Smith CL
    J Clin Pathol; 1979 Oct; 32(10):998-1002. PubMed ID: 230205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cyclic guanosine monophosphate in chronic heart failure: hemodynamic and neurohormonal correlations and response to nitrate therapy.
    Shotan A; Mehra A; Ostrzega E; Hsueh W; Do YS; Fisher DA; Hurst A; Johnson JV; Elkayam U
    Clin Pharmacol Ther; 1993 Dec; 54(6):638-44. PubMed ID: 7903916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between plasma and aortic wall cyclic guanosine monophosphate in an experimental model of congestive heart failure.
    Arnal JF; Hofmann F; Michel JB
    Cardiovasc Res; 1993 Jun; 27(6):1094-100. PubMed ID: 8221770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats.
    Michel JB; Mercadier JJ; Galen FX; Urbain R; Dussaule JC; Philippe M; Corvol P
    Cardiovasc Res; 1990 Nov; 24(11):946-52. PubMed ID: 2176935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cardiorenal Effects of Chronic Phosphodiesterase-V Inhibition in Preclinical Diastolic Dysfunction (Stage B Heart Failure).
    Vinnakota S; Adel FW; McKie PM; Scott CG; Chen HH
    J Card Fail; 2023 Oct; 29(10):1461-1465. PubMed ID: 37295665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma cyclic nucleotide concentrations in congestive heart failure.
    Ogawa K; Shiozu H; Mizuno K; Ban M; Ito T; Satake T
    Br Heart J; 1984 Nov; 52(5):524-9. PubMed ID: 6093837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANF-mediated renal cGMP generation in congestive heart failure.
    Margulies KB; Heublein DM; Perrella MA; Burnett JC
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.
    Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D
    Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclic GMP as a biomarker for cardiovascular disease and cancer].
    Ulvestad L; Sager G
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):27-8. PubMed ID: 15643459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.